Project Details
| Status | Active |
|---|---|
| Effective start/end date | 12/29/22 → 07/31/26 |
Funding
- Medpace Inc: $6,552.00
NGAM-12: Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients with Chronic Lymphocytic Leukemia
- Padhi, Parikshit (PI)
- Setlik, Robert (PI)
Project: Research